Selective progesterone receptor modulators (SPRMs): A novel therapeutic concept in endometriosis

Annals of the New York Academy of Sciences

Volumn 955, Issue , 2002, Pages 373-388

  Chwalisz, Kristof ^a   Garg, Ramesh ^a   Brenner, Robert M ^b   Schubert, Gerd ^c   Elger, Walter ^d  

^a TAP PHARMACEUTICAL PRODUCTS INC   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c BAYER PHARMA AG   (Germany)

^d EnTec GmbH   (Germany)

Author keywords

Endometriosis; Ovulation; SPRMs; Therapeutic; Treatment

Indexed keywords

11BETA (4 ACETYLPHENYL) 17BETA HYDROXY 17ALPHA (1,1,2,2,2 PENTAFLUOROETHYL)ESTRA 4,9 DIEN 3 ONE; ANTIGESTAGEN; ASOPRISNIL; DANAZOL; GESTAGEN; GESTRINONE; GONADORELIN AGONIST; J 1042; J 912; J 956; LILOPRISTONE; MIFEPRISTONE; ONAPRISTONE; PROGESTERONE RECEPTOR MODULATOR; PROMEGESTONE; UNCLASSIFIED DRUG; ZK 137316;

ABDOMINAL PAIN; ANIMAL EXPERIMENT; ANIMAL MODEL; CLINICAL FEATURE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; DRUG EFFECT; DRUG SELECTIVITY; DYSMENORRHEA; DYSPAREUNIA; ENDOMETRIOSIS; FEMALE; HIGH RISK POPULATION; HUMAN; MENSTRUATION; NONHUMAN; OVULATION; PELVIS PAIN SYNDROME; PHARMACODYNAMICS; SIDE EFFECT; SYMPTOM;

ANIMALIA;

EID: 0036218059     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2002.tb02798.x     Document Type: Conference Paper

References (31)

1. Angiogenesis: A new theory of endometriosis
2. Endometriosis and pain
3. Deeply infiltrating endometriosis is a disease, whereas mild endometriosis could be considered a non-disease
4. Endometriosis - A disease because it is characterized by bleeding
5. Drug therapy: Treatment of endometriosis
6. Endocrine-pharmacological characterization of progesterone antagonists and progesterone receptor modulators (PRMs) with respect to PR-agonistic and antagonistic activity
7. Synthesis and biological activity of a novel, highly potent progesterone antagonist
8. Endometrial and pituitary responses to the steroidal antiprogestin RU 486 in postmenopausal women
9. Modulation of estrogenic effects by progesterone antagonists in the rat uterus
10. Antiprogestational steroids: A new dimension in human fertility regulation
11. Clinical pharmacology of RU 486 - An antiprogestin and antiglucocorticoid
12. Mechanism of action of progesterone antagonists in pregnant guinea pigs
13. The use of progesterone antagonists for cervical ripening and as an adjunct to labour and delivery
14. Endometrial and myometrial effects of progesterone antagonists in pregnant guinea pigs
15. Antiproliferative effects of progesterone antagonists and progesterone receptor modulators on the endometrium
16. A comparison of the endometrial antiproliferative effects of a mesoprogestin (J1042) with the antiprogestins ZK 137 316 and ZK 230 211 in cynomolgus monkeys
17. Chronic treatment of cycling rhesus monkeys with low doses of the antiprogestin ZK 137 316: Morphometric assessment of the uterus and oviduct
18. Reversible suppression of menstruation with progesterone antagonists in rhesus macaques
19. Endometrial angiogenesis throughout the human menstrual cycle
20. Cyclic changes in the primate oviduct and endometrium
21. Noncompetitive antiestrogenic effect of RU 486 in blocking the estrogen-stimulated luteinizing hormone surge and the proliferative action of estradiol on endometrium in castrate monkeys
22. Contraceptive potential of RU 486 by ovulation inhibition: I. Pituitary versus ovarian action with blockade of estrogen-induced endometrial proliferation
23. RU 486 action after estrogen priming in the endometrium and oviducts of rhesus monkeys (Macaca mulatta)
24. Progesterone antagonists increase androgen receptor expression in the rhesus macaque and human endometrium
25. Changes in nitric oxide synthase are down-regulated by antiprogesterone in the stimulated-pregnant baboon uterus
26. Histological changes in the genital tract in transsexual women following androgen therapy
27. Histopathological effects of exogenously administered testosterone in 19 female to male transsexuals
28. The action of testosterone propionate on the uterus and breast
29. Expression of cyclooxygenase-1 and -2 in the baboon endometrium during the menstrual cycle and pregnancy
30. The selective receptor modulator, raloxifene: An overview on nonclinical pharmacology and reproductive and developmental testing
31. Molecular basis of treating endometriosis with aromatase inhibitors